...
首页> 外文期刊>BMC Cancer >Propensity-score-matching analysis to compare efficacy and safety between 16-gauge and 18-gauge needle in ultrasound-guided biopsy for peripheral pulmonary lesions
【24h】

Propensity-score-matching analysis to compare efficacy and safety between 16-gauge and 18-gauge needle in ultrasound-guided biopsy for peripheral pulmonary lesions

机译:倾向 - 分数匹配分析,以比较16-Cauge和18·仪表针在超声引导的外周肺病变中的疗效和18号针之间的疗效和安全性

获取原文
           

摘要

Definitive diagnosis of peripheral pulmonary lesions (PPLs) depends on the histological analysis of the pleural biopsy sample. Ultrasound (US)-guided sampling is now standard practice in the clinical setting. However, determining a suitable needle size and sampling times to improve the efficacy and safety of the biopsy remains challenging. Here, we compared the efficacy between 16- and 18-gauge core biopsy needles in US-guided percutaneous transthoracic biopsy for PPLs on histological diagnosis and procedure-related complications. In total, 1169 patients (767 men, 402 women; mean age, 59.4?±?13.2?years) who received biopsy for PPLs between September 2011 and February 2019 were included. The propensity score matching (PSM) analysis was performed to adjust the baseline differences, and the rate of successful specimen assessment and complications were compared between the 16-gauge (249 patients) and 18-gauge (920 patients) groups. The number of pleural surfaces crossed (NOPSC) was defined as the number of times the visceral pleural surface was transgressed. Stratified analysis was performed based on NOPSC. The overall success rate was 92.0% (1076/1169). The overall complication rate was 9.6%, including pneumothorax, hemorrhage, and vasovagal reaction, which occurred in 2.5% (29/1169), 6.6% (77/1169), and 0.5% (6/1169) of the patients, respectively. When NOPSC was 1 or??2, the success and complication rates in the 16-gauge group were comparable to those of the 18-gauge group (all P??0.05). When the NOPSC was 2, the success rate in the 16-gauge group was significantly higher than that in the 18-gauge group (P?=?0.017), whereas the complication rate was comparable (P??0.05). Higher success rate could be achieved using a 16-gauge than an 18-gauge core biopsy needle in the US-guided percutaneous transthoracic biopsy for PPLs when the NOPSC was 2. We recommend using 16-gauge needles with 2 times of needle passes in biopsy for PPLs in clinical practice.
机译:外周肺病变的明确诊断(PPLS)取决于胸腔活检样品的组织学分析。超声(US) - 模糊取样现在是临床环境中的标准练习。然而,确定合适的针尺寸和取样时间以改善活检的疗效和安全性仍然具有挑战性。在这里,我们将16-型核心活组织检查针对我们引导的经皮晶体活检的疗法核心活组织检查进行了比较了对组织学诊断和程序相关的并发症的PPL。总共1169名患者(767名男性,402名女性;平均年龄,59.4?±13.2?年)在2011年9月和2019年2月之间接受了对PPLS的活检。进行倾向评分匹配(PSM)分析以调整基线差异,比较16·仪表(249名患者)和18·仪表(920名患者)组之间的成功标本评估和并发症的速率。交叉(NOPSC)的胸膜曲面的数量定义为内脏胸膜表面违背的次数。基于NOPSC进行分层分析。总体成功率为92.0%(1076/1169)。整体并发症率为9.6%,包括肺炎,出血和血管养反应,分别发生在2.5%(29/1169),6.6%(77/1169)和患者的0.5%(6/1169)中发生。当NOPSC为1或& 2,16-Cauge组的成功和并发症率与18​​·仪表组的成功和并发症率相当(所有P?& 0.05)。当NOPSC为2时,16-Cauge组的成功率明显高于18·仪表组(P?= 0.017),而并发症率相当(p?& 0.05)。当NOPSC为2的PPLS中,使用16型速度比18·仪表核心活组织检查,可以使用16型仪核心活组织检查的成功率更高的成功率。我们建议使用16型仪针,在活检中使用2次针刺临床实践中的PPLS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号